Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
CF PHARMTECH (02652.HK) Inhalation Production Base Passes GMP Inspection by PIC/S Member Authority
Recommend 1 Positive 0 Negative 0 |
||||
|
||||
|
CF PHARMTECH (02652.HK) announced that its inhalation production base in Suzhou has recently passed an on-site Good Manufacturing Practice (GMP) compliance inspection conducted by a pharmaceutical regulatory authority from a member country of the Pharmaceutical Inspection Co-operation Scheme (PIC/S). The inspection covered the base’s production management and quality control systems, plant facilities and equipment, data integrity, as well as computerized systems. Passing the inspection confirms that the base’s quality management system and production capabilities comply with PIC/S GMP standards, opening up an important market access channel for the Group’s inhalation products. (sl/u) Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
